Clinical trial Recruiting at 1 site Observational Ages 20 to 50 Women only

How Saline Infusion Sonohysterography Helps Assess Cesarean Scar Defects

Official title: Preliminary Clinical Application Study of Saline Infusion Onohysterography in Structure of Cesarean Scar Surgery

Run by Tang-Du Hospital · NCT07610668 · Data updated 2026-11-12

This study tests whether saline infusion sonohysterography can reliably detect cesarean scar defects and guide treatment for people experiencing symptoms after cesarean delivery.

Quick facts

Study typeObservational
Ages20 Years to 50 Years
SexWomen only
Enrollment300 (estimated)
SponsorTang-Du Hospital
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedJune 30, 2026
Study endsJuly 31, 2026
Registry record updatedMay 28, 2026
Trial IDNCT07610668 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals more than 6 months past cesarean delivery with symptoms such as abnormal bleeding, dysmenorrhea, prolonged spotting, or secondary infertility who need SIS to evaluate the cesarean scar.

Probably not a fit

Patients without cesarean scar defects or without symptoms related to the cesarean scar may derive no direct benefit from this SIS-focused assessment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center observational study investigates the diagnostic value of saline infusion sonohysterography (SIS) in evaluating cesarean scar incision structure. Researchers compare SIS findings with hysteroscopy, MRI, and conventional ultrasound to assess detection of cesarean scar diverticula, changes in diverticulum size, and the residual myometrial thickness. Patients with prior cesarean delivery who require SIS and have related symptoms are followed after diverticulum reconstruction to monitor symptom improvement and prognosis for up to one year. The goal is to determine how SIS can support clinical decision-making and patient outcomes, potentially informing standardized assessment and surgical planning. Safety and data completeness are considered through well-defined inclusion and exclusion criteria and follow-up.

Why it matters

Potential benefit: If successful, SIS could improve preoperative diagnosis and help tailor surgical decisions to improve symptom relief and reduce complications.

How similar studies have gone: Previous research in similar imaging approaches has shown promise in characterizing cesarean scar defects, supporting the potential value of SIS in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* More than 6 months after cesarean delivery;
* Presenting with clinical symptoms-including abnormal uterine bleeding, dysmenorrhea, prolonged menstrual spotting, or secondary infertility;
* Requiring saline infusion sonohysterography (SIS) to evaluate the cesarean scar.

Exclusion Criteria:

* Multiple cesarean deliveries;
* Patients contraindicated for saline infusion sonohysterography (SIS), including pregnancy or suspected pregnancy, failure to meet vaginal hygiene criteria, inability to cooperate during the procedure, or suboptimal image quality;
* Cases with incomplete clinical data or lost to follow-up.

Where it's running

  • Tang-Du Hospital
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.